BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+3.37%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$957M
AUM Growth
+$1.08M
(+0.11%)
Cap. Flow
-$8.63M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
32.99%
Holding
140
New
9
Increased
34
Reduced
55
Closed
6
Top Buys
| 1 |
DexCom
DXCM
|
$12.7M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.1M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$9.58M |
| 4 |
Incyte
INCY
|
$8.07M |
| 5 |
CELG
Celgene Corp
CELG
|
$7.5M |
Top Sells
| 1 |
Amgen
AMGN
|
$20.3M |
| 2 |
Gilead Sciences
GILD
|
$15.9M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$10.9M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$8.6M |
| 5 |
AbbVie
ABBV
|
$8.05M |
Sector Composition
| 1 | Healthcare | 95.72% |
| 2 | Financials | 0.41% |
| 3 | Industrials | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Gilead Sciences
GILD
$140B
| $13M | 1.36% |
181,100
-221,441
| -55% | -$15.9M |
|
27
Ionis Pharmaceuticals
IONS
$9.64B
| $12.9M | 1.35% |
256,706
-9,000
| -3% | -$453K |
|
28
Teva Pharmaceuticals
TEVA
$21.5B
| $12.7M | 1.33% |
671,940
+90,000
| +15% | +$1.71M |
|
|
WMGI
29
DELISTED
Wright Medical Group Inc
WMGI
| $12M | 1.26% |
541,801
| – | – |
|
30
Becton Dickinson
BDX
$54.3B
| $11.8M | 1.23% |
56,375
| – | – |
|
31
LivaNova
LIVN
$3.09B
| $11.8M | 1.23% |
147,269
-10,800
| -7% | -$863K |
|
32
Cigna
CI
$80.2B
| $11.7M | 1.22% |
57,650
+10,000
| +21% | +$2.03M |
|
33
Centene
CNC
$14.8B
| $11.6M | 1.22% |
230,780
-7,080
| -3% | -$357K |
|
|
HZNP
34
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11.6M | 1.21% |
794,062
+307,599
| +63% | +$4.49M |
|
35
MacroGenics
MGNX
$121M
| $10.7M | 1.12% |
564,401
+131,102
| +30% | +$2.49M |
|
36
Regeneron Pharmaceuticals
REGN
$59.8B
| $10.5M | 1.09% |
27,800
-2,400
| -8% | -$902K |
|
|
ONC
37
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $10.1M | 1.06% |
+103,650
| New | +$10.1M |
|
38
Zimmer Biomet
ZBH
$20.8B
| $10M | 1.05% |
85,490
-10,300
| -11% | -$1.21M |
|
39
Viatris
VTRS
$12.3B
| $10M | 1.04% |
236,300
+55,100
| +30% | +$2.33M |
|
|
40
Supernus Pharmaceuticals
SUPN
$2.52B
| $9.58M | 1% |
+240,400
| New | +$9.58M |
|
41
Tenet Healthcare
THC
$16.5B
| $9.34M | 0.98% |
616,796
| – | – |
|
42
Labcorp
LH
$22.8B
| $9.06M | 0.95% |
66,138
+2,490
| +4% | +$341K |
|
|
SHPG
43
DELISTED
Shire pic
SHPG
| $8.75M | 0.91% |
56,435
+13,995
| +33% | +$2.17M |
|
44
Integra LifeSciences
IART
$1.18B
| $8.72M | 0.91% |
182,200
+5,350
| +3% | +$256K |
|
45
Humana
HUM
$37.5B
| $8.27M | 0.86% |
33,350
+2,000
| +6% | +$496K |
|
|
TSRO
46
DELISTED
TESARO, Inc.
TSRO
| $5.98M | 0.62% |
72,100
+61,100
| +555% | +$5.06M |
|
47
HUTCHMED
HCM
$2.62B
| $5.26M | 0.55% |
133,850
+69,277
| +107% | +$2.72M |
|
|
ABMD
48
DELISTED
Abiomed Inc
ABMD
| $5.06M | 0.53% |
27,000
-58,110
| -68% | -$10.9M |
|
49
Thermo Fisher Scientific
TMO
$183B
| $4.9M | 0.51% |
25,808
| – | – |
|
50
Cooper Companies
COO
$13.3B
| $4.86M | 0.51% |
89,200
-6,800
| -7% | -$370K |
|